ReShape Lifesciences Inc. (RSLS) has 69 open-market insider trades by 7 insiders since 2019. The most active filer is Thomas Stankovich, CFO.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Steven Boyd | 10% Owner | — | 10 | $28.7M | 2021-06-28 |
| Barton P. Bandy | CEOPres | — | 12 | $1.9M | 2022-08-05 |
| Thomas Stankovich | CFO | — | 27 | $677K | 2024-05-31 |
| Dan W. Gladney | Dir | — | 1 | $598K | 2021-09-10 |
| Armistice Capital, LLC via Steven Boyd | 10% | — | 9 | $135K | 2021-06-15 |
| SABBY Management, LLC | 10% | — | 6 | $81K | 2019-01-31 |
| Armistice Capital Master Fund Ltd. | 10% | — | 4 | $48K | 2020-11-10 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Thomas Stankovich | CFO | Sell | $39 | 2023-11-30 |
| Thomas Stankovich | CFO | Sell | $386 | 2023-08-04 |
| Thomas Stankovich | CFO | Sell | $156 | 2023-07-06 |
| Thomas Stankovich | CFO | Buy | $27K | 2023-06-30 |
| Thomas Stankovich | CFO | Sell | $746 | 2023-03-31 |
| Thomas Stankovich | CFO | Sell | $4K | 2023-01-24 |
Companies that share insiders with RSLS, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| Thomas Stankovich | CFO | Sell | $125K | 2022-11-28 |
| Thomas Stankovich | CFO | Sell | $2K | 2022-11-04 |
| Thomas Stankovich | CFO | Sell | $2K | 2022-10-04 |
| Thomas Stankovich | CFO | Sell | $2K | 2022-09-06 |
| Thomas Stankovich | CFO | Sell | $2K | 2022-08-05 |
| Barton P. Bandy | President | Sell | $5K | 2022-08-05 |
| Thomas Stankovich | CFO | Sell | $3K | 2022-07-01 |
| Barton P. Bandy | President | Sell | $6K | 2022-07-01 |
| Thomas Stankovich | CFO | Sell | $4K | 2022-06-01 |